Literature DB >> 17618309

Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells.

A Teymoortash1, F Sommer, R Mandic, S Schulz, M Bette, G Aumüller, J A Werner.   

Abstract

BACKGROUND AND
PURPOSE: Intraglandular injection of botulinum toxin (BoNT) leads to a transient denervation of the submandibular gland and this is associated with reduced salivary secretion. The purpose of the present study was to verify whether temporary acinar atrophy occurs simultaneously with chemical denervation of the glands. EXPERIMENTAL APPROACH: Tissue specimens of the right submandibular gland taken from 18 Wistar rats after intraglandular injection of BoNT A, BoNT B, or a combination of both were examined. As a sham control, an equivalent volume of saline was injected into the left submandibular gland. Morphometric measurements, immunohistochemistry, electron microscopy and western blot analysis were used to analyse the morphological and functional changes of the denervated glands. KEY
RESULTS: Morphological and ultrastructural analyses of the cell organelles and secretory granula showed a clear atrophy of the acini, which was more prominent in glands injected with the combination of BoNT/A and B. Morphometric measurements of the glandular acini revealed a significant reduction of the area of the acinar cells after injection of BoNT (P=0.031). The expression of amylase was significantly reduced in BoNT treated glands. CONCLUSIONS AND IMPLICATIONS: Intraglandular application of BoNT induces structural and functional changes of the salivary glands indicated by glandular atrophy. These effects may be due to glandular denervation induced by the inhibition of the soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors (SNAREs) involved in acetylcholine release at the neuroglandular junction and also specially inhibition of those involved in exocytosis of the granula of the acinar cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618309      PMCID: PMC1978275          DOI: 10.1038/sj.bjp.0707375

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Supersensitivity of salivary gland caused by botulinum toxin.

Authors:  N EMMELIN
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

2.  Secretory responses in granular ducts and acini of submandibular glands in vivo to parasympathetic or sympathetic nerve stimulation in rats.

Authors:  J R Garrett; A M Suleiman; L C Anderson; G B Proctor
Journal:  Cell Tissue Res       Date:  1991-04       Impact factor: 5.249

Review 3.  The proper role of nerves in salivary secretion: a review.

Authors:  J R Garrett
Journal:  J Dent Res       Date:  1987-02       Impact factor: 6.116

Review 4.  Nerve interactions in salivary glands.

Authors:  N Emmelin
Journal:  J Dent Res       Date:  1987-02       Impact factor: 6.116

5.  Presence of a complex containing vesicle-associated membrane protein 2 in rat parotid acinar cells and its disassembly upon activation of cAMP-dependent protein kinase.

Authors:  J Fujita-Yoshigaki; Y Dohke; M Hara-Yokoyama; S Furuyama; H Sugiya
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

6.  Immunohistochemical and morphometric investigations of the influence of botulinum toxin on the submandibular gland of the rat.

Authors:  M Ellies; R Laskawi; W Götz; C Arglebe; G Tormählen
Journal:  Eur Arch Otorhinolaryngol       Date:  1999       Impact factor: 2.503

7.  Increase of muscarinic cholinergic receptors in the rat submandibular glands after parasympathectomy and repeated administration of haloperidol.

Authors:  J H Pazo; S Rascovsky; D Jerusalinsky; J H Medina; O R Tumilasci
Journal:  Gen Pharmacol       Date:  1989

8.  Vesicle-associated membrane protein 2 is essential for cAMP-regulated exocytosis in rat parotid acinar cells. The inhibition of cAMP-dependent amylase release by botulinum neurotoxin B.

Authors:  J Fujita-Yoshigaki; Y Dohke; M Hara-Yokoyama; Y Kamata; S Kozaki; S Furuyama; H Sugiya
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

Review 9.  Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells.

Authors:  J Fujita-Yoshigaki
Journal:  Cell Signal       Date:  1998-06       Impact factor: 4.315

10.  The fine structure of the gastric mucosa in the bat.

Authors:  S ITO; R J WINCHESTER
Journal:  J Cell Biol       Date:  1963-03       Impact factor: 10.539

View more
  15 in total

1.  Effect of botulinum toxin type a on morphology of salivary glands in patients with cerebral palsy.

Authors:  Zee-Ihn Lee; Dong-Hyun Cho; Won-Duck Choi; Dong-Hwi Park; Seung-Deuk Byun
Journal:  Ann Rehabil Med       Date:  2011-10-31

Review 2.  [Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective].

Authors:  C Wittekindt; H P Burmeister; O Guntinas-Lichius
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 4.  [Botulinum toxin in otorhinolaryngology - an update].

Authors:  R Laskawi; A Olthoff
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

Review 5.  A review on use of botulinum toxin for intractable lacrimal drainage disorders.

Authors:  Swati Singh; Mohammad Javed Ali; Friedrich Paulsen
Journal:  Int Ophthalmol       Date:  2017-08-01       Impact factor: 2.031

6.  Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogenous acetylcholine.

Authors:  M Shibasaki; S L Davis; J Cui; D A Low; D M Keller; C G Crandall
Journal:  Br J Dermatol       Date:  2009-04-22       Impact factor: 9.302

Review 7.  Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.

Authors:  Harshad R Kulkarni; Aviral Singh; Thomas Langbein; Christiane Schuchardt; Dirk Mueller; Jingjing Zhang; Coline Lehmann; Richard P Baum
Journal:  Br J Radiol       Date:  2018-06-01       Impact factor: 3.039

8.  Botulinum toxin A inhibits salivary secretion of rabbit submandibular gland.

Authors:  Xiao-Feng Shan; Hui Xu; Zhi-Gang Cai; Li-Ling Wu; Guang-Yan Yu
Journal:  Int J Oral Sci       Date:  2013-10-25       Impact factor: 6.344

Review 9.  Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality.

Authors:  Yu-Chao Hsu; Hung-Jen Wang; Yao-Chi Chuang
Journal:  Toxins (Basel)       Date:  2016-04-26       Impact factor: 4.546

10.  Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial.

Authors:  Afshin Teymoortash; Andreas Pfestroff; Andrea Wittig; Nora Franke; Stephan Hoch; Susanne Harnisch; Carmen Schade-Brittinger; Helmut Hoeffken; Rita Engenhart-Cabillic; Markus Brugger; Konstantin Strauch
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.